Cerebain Biotech Announces Completion of Phase 1A of Its Medical Device Product Development

Published: Oct 02, 2012

DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced today that medical device product development company, Sonos Models, Inc. (“Sonos”), has completed Phase 1A of its medical device solution and will begin Phase 1B which will research the Omentum and related patents and literature to obtain a better comprehension of the Omentum as a basis for designing the fluid extraction device.

Back to news